EU CHMP recommends approval of Merck’s Keytruda plus Padcev as perioperative treatment for adults with cisplatin-ineligible resectable muscle-invasive bladder cancer: Rahway, Ne ...

All of them could be "forever" holdings, but the coming decade could prove surprisingly fruitful for each of these outfits.

Your brain isn't recording reality. It's predicting it. Understanding that one shift explains why psychedelics heal, why therapy matters, and why resistance isn't what we think.

A new experiment is seeking to validate whether living cancer samples can be prepared, operated, monitored, and recovered ...

A single infusion of an experimental gene-editing drug seemed to reduce LDL long-term in a small trial. The results may point to something “curative,” one expert said.

New NIH research reveals that semaglutide sparks different responses inside appetite-controlling brain cells, offering fresh insight into why GLP-1 weight-loss drugs don’t work the same for everyone.

A new review highlights the emerging importance of YTHDF2, a key regulator of RNA activity, in shaping the body's inflammatory responses and influencing a wide range of diseases.